NasdaqGS - Delayed Quote USD

Arbutus Biopharma Corporation (ABUS)

3.5300
-0.0500
(-1.40%)
At close: June 13 at 4:00:02 PM EDT
3.6000
+0.07
+(1.98%)
After hours: June 13 at 5:54:46 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 2.46M
Earnings -34.27M

Q2'24

Q3'24

Q4'24

Q1'25

-30M
-20M
-10M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

4.11
5.40 Average
3.5300 Current
7.20 High

Earnings Estimate

Currency in CAD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 2222
Avg. Estimate -0.09-0.08-0.43-0.38
Low Estimate -0.1-0.1-0.45-0.41
High Estimate -0.08-0.07-0.42-0.35
Year Ago EPS -0.15-0.14-0.54-0.43

Revenue Estimate

Currency in CAD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 4443
Avg. Estimate 2.22M2.19M7.85M6.18M
Low Estimate 1.4M1.26M5.18M3.92M
High Estimate 2.52M2.52M9.92M9.86M
Year Ago Sales 2.39M1.86M8.8M7.85M
Sales Growth (year/est) -6.92%18.02%-10.84%-21.28%

Earnings History

Currency in CAD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. -0.13-0.13-0.12-0.15
EPS Actual -0.15-0.14-0.1-0.18
Difference -0.02-0.010.02-0.03
Surprise % -16.93%-6.91%14.48%-18.14%

EPS Trend

Currency in CAD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.09-0.08-0.43-0.38
7 Days Ago -0.06-0.06-0.33-0.14
30 Days Ago -0.06-0.06-0.33-0.14
60 Days Ago -0.12-0.12-0.48-0.59
90 Days Ago -0.12-0.12-0.47-0.57

EPS Revisions

Currency in CAD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 2231
Up Last 30 Days 2231
Down Last 7 Days ----1--
Down Last 30 Days ----1--

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ABUS 40.25%39.37%20.02%12.92%
S&P 500 13.13%2.40%7.54%14.08%

Upgrades & Downgrades

Maintains Chardan Capital: Buy to Buy 3/28/2025
Reiterates HC Wainwright & Co.: Buy to Buy 1/21/2025
Maintains Chardan Capital: Buy to Buy 11/20/2024
Reiterates HC Wainwright & Co.: Buy to Buy 11/18/2024
Reiterates HC Wainwright & Co.: Buy to Buy 11/7/2024
Maintains Chardan Capital: Buy to Buy 11/7/2024

Related Tickers